Videos de Conceptos Relacionados
También podría leer
Artículos Relacionados
Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.
Ordenar por
Same author
Comparable recurrence risk for MRI-detected Gleason Grade Group (GG) 2 and systematic biopsy-detected GG1 prostate cancer.
BJU international·2025
Same author
Erectile and urinary function in patients on active surveillance for prostate cancer: results from the Finnish arm of the PRIAS trial.
Scandinavian journal of urology·2025
Same author
Long-term outcomes of active surveillance for Grade Group 1 prostate cancer and the impact of the use of MRI on overtreatment.
BJU international·2025
Same author
Enzalutamide in patients with high-risk biochemically recurrent prostate cancer according to the European Association of Urology definition: a post hoc analysis of EMBARK.
Prostate cancer and prostatic diseases·2025
Same author
Association of prostate-specific antigen density with prostate cancer mortality after a benign systematic prostate biopsy result.
BJU international·2025
Same author
Protocol of a randomised, controlled trial comparing immediate curative therapy with conservative treatment in men aged ≥75 years with non-metastatic high-risk prostate cancer (SPCG 19/GRand-P).
BJU international·2024
Same journal
Long-term outcomes of adjuvant metronomic capecitabine in locoregionally advanced nasopharyngeal carcinoma: a randomized, controlled, multicenter, phase 3 study.
Nature cancer·2026
Same journal
Inhibition of ADSS2-mediated de novo AMP biosynthesis re-sensitizes acute myeloid leukemia to BH3 mimetics.
Nature cancer·2026
Same journal
GABA signaling activation drives glioblastoma progression in female mice through myeloid-derived suppressor cells.
Nature cancer·2026
Same journal
The future of tertiary lymphoid structures in cancer immunotherapy as biomarkers and therapeutic targets.
Nature cancer·2026
Same journal
Targeting PID1 generates oxysterols to switch macrophage cell fates for improved antitumor immunity.
Nature cancer·2026


